Vascular Disease Prospective-Retrospective Observational Registry for Aortic Aneurysm and Peripheral Artery Disease

Ju Yeon Choi1,2, Tae Oh Kim3, Jun Gyo Gwon1

  • 1Division of Vascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Insights

The VAPOR registry in Korea collects integrated data on peripheral artery disease (PAD) and aortic aneurysm (AA) to improve vascular care. This real-world evidence supports precision medicine and better patient outcomes for atherosclerosis.

Area of Science:

  • Vascular Surgery
  • Cardiovascular Research
  • Epidemiology

Background:

  • Peripheral artery disease (PAD) and aortic aneurysm (AA) are significant manifestations of systemic atherosclerosis.
  • Despite shared risk factors and pathways, integrated long-term data for both conditions are limited in Korea.
  • This data scarcity hinders real-world evidence generation and outcome evaluation for vascular diseases.

Purpose of the Study:

  • To establish the Vascular disease Prospective-Retrospective Observational Registry (VAPOR) in Korea.
  • To systematically collect clinical, imaging, and procedural data for patients with AA and PAD.
  • To identify shared and disease-specific risk factors, evaluate outcomes, and support precision vascular medicine.

Main Methods:

  • VAPOR is a mixed retrospective-prospective registry, initially single-centered with plans for multicenter expansion.
  • It collects comprehensive data on patients diagnosed with AA and/or PAD.
  • The registry is designed to facilitate risk stratification and the development of an interoperable vascular data infrastructure.

Main Results:

  • As of April 15, 2026, VAPOR enrolled 5,249 patients (4,438 retrospective, 811 prospective).
  • The cohort includes 2,193 patients with AA, 3,287 with PAD, and 231 with both conditions.
  • Primary outcomes focus on major adverse cardiovascular and limb events, alongside aneurysm/procedure-related events.

Conclusions:

  • The VAPOR registry offers a valuable real-world dataset for assessing treatment outcomes and long-term prognoses in patients with AA or PAD.
  • Its integrated retrospective and prospective data, with multicenter expansion potential, is a significant advancement for Korean vascular surgery.
  • VAPOR is poised to enhance evidence-based management and promote precision vascular care.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...